Dr. Peter de B. Harrington, Professor of Chemistry & Biochemistry, was quoted in a Forbes article headlined “5 Critical Questions Cannabis Researchers And Producers Are Asking in 2019.”
Cannabis is an entirely new world for scientists, who were largely unable to access the plant for research in days past. The process of categorizing cannabis into sets by their natural product content is still a long way from complete in the industry’s nascent stages. The effectiveness of cannabis to deliver the desired outcome depends on the interaction of several or all of the active ingredients found in the plant as a whole. Classifications far beyond “Sativa” and “Indica” designations are needed that connect with actual user experiences.
Speaking with Jack Rudd of Analytical Cannabis, Peter Harrington, professor of chemistry at Ohio University, explained the goal of chemotyping as “the process of grouping cannabis into classes based on their observed chemical composition, correlate these groups with desired pharmacological properties, so that industry can have some quality control over products and provide an avenue to achieve personalized medicine.”
Read the Analytical Cannabis article headlined “Chemotyping: Classifying cannabis strains by chemical composition.”
Comments